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Thomas J Simpson 
Background: It has been proposed that Streptomyces malonyl CoA:holo acyl 
carrier protein transacylases (MCATS) provide a link between fatty acid and 
polyketide biosynthesis. Two recent studies have provided evidence that the 
presence of MCAT is essential for polyketide synthesis to proceed in 
reconstituted minimal polyketide synthases (PKSs). In contrast to this, we 
previously showed that the holo acyl carrier proteins (ACPs) from type II PKSs 
are capable of catalytic self-malonylation in the presence of malonyl CoA, which 
suggests that MCAT might not be necessary for polyketide biosynthesis. 
Results: We reconstituted a homologous actinorhodin (act) type II minimal 
PKS in vitro. When act ho/o-ACP is present in limiting concentrations, MCAT is 
required by the synthase complex in order for polyketide biosynthesis to 
proceed. When ho/o-ACP is present in excess, however, efficient polyketide 
synthesis proceeds without MCAT. The rate of polyketide production increases 
with ho/o-ACP concentration, but at low ACP concentration or equimolar 
ACP:KS:CLF (KS, ketosynthase; CLF, chain length determining factor) 
concentrations this rate is significantly lower than expected, indicating that free 
ho/o-ACP is sequestered by the KSlCLF complex. 
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Conclusions: The rate of polyketide biosynthesis is dictated by the ratio of 
ho/o-ACP to KS and CLF, as well as by the total protein concentration. There is 
no absolute requirement for MCAT in polyketide biosynthesis in vitro, although 
the role of MCAT during polyketide synthesis in viva remains an open question. 
MCAT might be responsible for the rate enhancement of malonyl transfer at 
very low free ho/o-ACP concentrations or it could be required to catalyse the 
transfer of malonyl groups from malonyl CoA to sequestered ho/o-ACP. 
Introduction 
The enzymes that govern the assembly of polyketides by 
microorganisms are receiving increasing attention as access 
to them has improved through molecular genetic methods 
[l]. In particular, the biosynthesis of polycyclic aromatic 
compounds such as actinorhodin (act) and tetracenomycin 
(tcm) (Figure 1) by Streptomyces type II polyketide synthases 
(PKSs) has been studied extensively in r&o [Z-4] and, more 
recently, in vitro [S-7]. Experiments by Hutchinson, Khosla 
and others have shown that expression of ‘minimal PKS’ 
systems consisting of open reading frames (ORFs) coding 
for P-keto acyl synthase (KS), chain length factor (CLF) and 
acyl carrier proteins (ACP) produce protein complexes that 
are capable of synthesising polyketides such as the octake- 
tides SEK4 and SEK4b (act genes) and the decaketide 
SEK15 (tcm genes) in oivo. These experiments have been 
carried out in Streptopnyces species in which endogenous PKS 
genes are missing or have been deleted. The in vivo experi- 
ments are unable to determine whether a functioning 
minimal PKS expressed in a streptomycete is interacting 
with any other endogenous proteins, however. Of particular 
interest in this respect are proteins involved in the parallel 
pathway of fatty acid biosynthesis. [Act1 ORFZ is a protein 
of significant similarity to act1 ORFl, which encodes the p- 
keto acyl ACP synthase (KS). Act1 ORFZ, however, does not 
possess an active-site cysteine essential for KS activity. 
Although essential for PKS activity, the precise role of the 
act1 ORFZ gene product is unknown. Early in viva ‘mix and 
match’ expression experiments suggested that this protein 
controlled final polyketide chain length, hence the name 
‘chain length factor (CLF)‘. More recent experiments have 
shown that chain length is controlled in a more complex 
way by interactions between the act1 ORFl and act1 ORFZ 
gene products as well as other proteins [S]. The alternative 
nomenclature systems of KS, (KS) and KSB (CLF) is no less 
unsatisfactory as the act1 ORFZ gene product is clearly not a 
KS. ‘CLF’ will remain in use here until a better understand- 
ing of this protein’s role is forthcoming.] 
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Structures of polyketides produced by type II polyketide synthases. 
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Fatty acids are biosynthesised in gram-negative and 
gram-positive bacteria using classical type II fatty acid 
synthase (FAS) systems. In &&ric/ria co/i, malonyl ACP 
is the component that provides malonyl extender groups 
for growing fatty acids, which are themselves held as 
acyl thiolesters of ACP [9]. Malonyl ACP formation from 
malonyl CoA is catalysed by malonyl CoA : dolo-ACP 
transacylase (MCAT) [lo-121. A similar set of FAS genes 
has been shown to exist in Streptomyces coelicolor. The 
putative S. coelicolor fab cluster contains genes homolo- 
gous to the E. cofi FAS ketoacylsynthases (KAS) I and III, 
ACP and MCAT, and the cluster would seem to consist 
of all the genes necessary for fatty acid biosynthesis. In 
contrast, the act cluster of S. coelicolor, which contains all 
the genes required for actinorhodin biosynthesis, does not 
seem to code for activities that might be thought neces- 
sary for synthesis. Although KS and ACP genes are 
present, there is no ORF that codes for an MCAT homo- 
logue. In the case of the act cluster, early sequencing 
results suggested a putative general acyl transferase (AT) 
domain (GHSXG) as part of act1 ORFl; other homolo- 
gous ORFs, such as tcmK (KS), contain similar motifs 
[13]. Mutagenesis experiments using both act1 ORFl [14] 
and tcmK [ 151 showed the putative active-site serine to be 
unnecessary for polyketide synthesis. In the case of dauno- 
rubicin (dps), a discrete gene has been identified (dp.rD) 
that is homologous to an acyl transferase. Even though 
this gene is part of the dps PKS cluster, it is not required 
for polyketide biosynthesis. Experiments involving dele- 
tion of dpsD showed that the correct starter propionyl unit 
was still incorporated into the polyketide [ 16,171. Thus, 
although AT-like domains have been found in a small 
number of type II PKS clusters, their function in VZ’UO is 
uncertain. This is a surprising result, in view of the large 
number of AT domains required for polyketide biosyn- 
thesis in type I modular systems such as erythromycin and 
rapamycin [18], as well as the absolute requirement for 
MCAT during fatty acid biosynthesis. 
Isolation and characterisation of Sfrepfomyces MCAT 
MCAT was isolated by Revill and Hopwood [19] from 
extracts of S. coehcolor using an assay based on the transfer 
of I%-malonyl groups from 14C-malonyl CoA to wild-type 
act Role-ACP. Purification of MCAT led to protein sequenc- 
ing and eventual location offabD (MCAT) on the S. coeL 
co/or chromosome. Sequencing indicated high homology 
to the E. co/i FAS MCAT originally isolated by Williamson 
and Wakil [lo] using E. coli FAS ACP. Contemporaneously 
Hutchinson and coworkers [20,21] reported similar work 
using Streptomyces glazlcscens from which MCAT was iso- 
lated and purified, using the tcm ACP expressed and 
purified separately from S. glazccescens. The conclusions of 
Revill and Hutchinson and coworkers [19-211 led to the 
proposal that MCAT could also catalyse the malonyl trans- 
fer required for efficient polyketide biosynthesis &z viva. 
In order to examine further the biochemistry of S. coeL 
color MCAT we have cloned and expressed it in E. co/i as a 
His, fusion protein (T.S Hitchman, R.J.C., J.C. and T.J.S, 
unpublished observations). The overexpressed protein was 
purified to homogeneity and characterised in detail. As 
expected, the purified protein catalyses the transfer of 
malonyl groups from malonyl CoA to S. coelicolor FAS 
ACP. The reaction between S. coelicolor MCAT and E. coli 
ACP is also catalysed, although the specificity (k,,,/K,) of 
MCAT for the E. co/i ACP is lower. 
Self-malonylation of ho/o-ACP 
In light of the above results we were surprised, during the 
course of the above studies with overexpressed HisG- 
MCAT, to observe that rigorously purified act /roLo-ACP 
can rapidly and catalytically self-malonylate in the pres- 
ence of malonyl CoA [Z?]. We have extensively charac- 
terised this reaction and have found that the MCAT has no 
measurable effect except at limiting ho/o-ACP concentra- 
tions. In contrast to the type II PKS ACPs, the FAS ACPs 
examined did not show this property. Our results of the 
study of PKS ACP self-acylation showed a typical kinetic 
profile with a reaction rate that increases with malonyl CoA 
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concentration, with eventual saturation at high malonyl 
CoA concentrations. The measured K, of about 200 pM for 
malonyl CoA in the self-malonylation reaction, and k,,, 
value of 0.34 min-1 suggested that this self-catalysed mal- 
onylation could account for polyketide synthesis without 
the need for MCAT activity and hence account for the 
lack of this activity in type II PKS gene clusters. Addition- 
ally, we investigated the substrate specificity of self-acyla- 
tion and show that the transfer of various B- and y-0x0 acyl 
groups (e.g. methylmalonyl, acetoacetyl and succinyl) is 
possible, whereas self-catalytic transfer of straight chain sat- 
urated acyl groups (e.g. acetyl and butyryl) is not. 
Reconstruction of minimal PKS systems in vitro 
More recent work has focused on the reconstitution of 
active type II PKS systems in vitro. Carreras and Khosla 
[23] used a heterologous system containing act KS/CLF 
and frenolicin (fren) ACP. Although crude preparations 
were capable of polyketide biosynthesis, this ability was 
lost on further purification of KS/CLF, enabling purifica- 
tion of a protein subsequently shown to be MCAT from 
S. coelicolor (based on its ability to restore PKS activity to 
the in vitro system). Khosla and Walsh and coworkers [S] 
have also reported the reconstruction of heterologous PKS 
systems using act KS/CLF obtained as a semi-pure frac- 
tion from S. coelicolor CH999 pSEK38. Fren and granaticin 
(gra). Ape-ACPs were treated with holo-ACP synthetase 
(ACPS) and acyl CoAs to form >95% acylated ho/o-ACPs. 
Fren acetyl ACP prepared in this way was shown to be an 
effective starter unit for polyketide synthesis. 
Hutchinson and coworkers [24] have also recently reported 
the in vitro reconstitution of a type II minimal PKS. Their 
strategy differed from that of Carreras and Khosla [23] in 
that KS/CLF was expressed separately from ACP. Using 
the tcm minimal genes tcmK (KS) and tcmL (CLF) with 
tcmM (ACP), together with the cyclase tcmiv, a reconsti- 
tuted assay produced the polyketide tcmF2 (Figure 1)‘ 
when supplemented with malonyl CoA and MCAT. Bao 
et al. [24] did observe a level of self-catalysed malonyl 
transfer to tcmM ACP, although the rate was significantly 
lower than that catalysed by MCAT. These results are in 
agreement with our previously reported results showing 
self-acylation of act /iolo-ACP in the presence of malonyl 
CoA. Despite the initial claim by these authors that 
MCAT is an ‘absolute requirement’ for polyketide produc- 
tion, it is clear that self-malonylation of ho/o-ACP could 
account for a proportion (up to 10% of the reported levels) 
of the polyketide produced. 
The absence of MCAT genes in the type II PKS clusters, 
and the evidence that MCAT stimulates polyketide pro- 
duction in vitro, has led to the proposal that endogenous 
Streptomyces FAS MCAT proteins perform the role of 
loading malonyl groups onto the PKS ACPs. Our recent 
results suggested that self-malonylation could account for 
polyketide biosynthesis by minimal PKS systems and 
therefore that MCAT might not be required for the 
activity of type II minimal PKS proteins [ZZ]. Here, we 
examine further the requirement for S. coelicolor MCAT 
in a reconstituted homologous act minimal PKS. In doing 
so, we address a number of points of apparent contradic- 
tion between our results and those of others. The results 
re-open the question of whether MCAT is essential for 
polyketide biosynthesis in vivo and begin to probe the 
exact roles of ACP and MCAT. 
Results 
Expression and purification of ho/o-ACPs 
Acyl carrier proteins were purified from their appropriate 
E. coli expression strains according to published methods 
[ZS]. The ACPs were shown to be free from E. co/i MCAT 
using procedures discussed previously [ZZ]. Importantly, it 
was ensured that ACPs used for the work described below 
were present in > 95% active Role form containing the 
4’-phosphopantetheine prosthetic group attached as a phos- 
phoester to the essential serine (Ser42) residue. This was 
achieved through the co-expression of ACP with E. coli holo- 
ACP synthetase (ACPS), as previously discussed [26], which 
is necessary to obtain high levels of active holo protein. Inac- 
tive apo protein was removed using chromatography. 
It was necessary also to ensure that the holo-ACPs were 
present in the correct form. We previously demonstrated 
rapid disulphide formation between the thiols of the 
4’-phosphopantetheine of holo-ACPs to form dimers in 
buffers containing insufficient (less than 1mM) dithiothre- 
itol (DTT) [26]. In the case of wild-type act ACP, rapid 
formation of an internal disulphide between the 4’-phos- 
phopantetheine and Cysl7 also occurs: we surmounted 
this particular problem by the formation of a Cysl7dSer 
(C17S) mutant [27]. We found that sodium dodecyl sul- 
phate polyacrylamide gel electrophoresis (SDS PAGE) 
cannot separate ACP monomers and disulphide dimers, so 
we utilised native PAGE, as well as electrospray mass 
spectroscopy (ESMS), to demonstrate that the ACPs were 
present as the active Aolo monomers (Figure 2 for act C17S 
AoLo-ACP data). As controls, disulphide dimers of the holo- 
ACPs were formed either by freeze drying, or by desalting 
against a buffer without DTT using a sepharose column. 
When freeze-dried holo-ACPs are resuspended in buffers 
containing 1mM DTT, monomerisation occurs, but on a 
slow time scale such that even after 45 min significant 
amounts of dimer remain. Increasing the amount of DTT 
can speed up the process (data not shown). 
Reconstitution of polyketide biosynthesis in vitro 
After initial cloning work in E. co/i, a clone was con- 
structed in pIJ4122 that consisted of an initial His, 
sequence followed by act1 ORFl (KS) and act1 ORFZ 
(CLF). The putative translational coupling between 
ORFs 1 and 2 was not altered [13]. After transformation 
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Slow monomerization of act Cl 7s ho/o-ACP in 1 mM DlT at 30%. 
(a) 17.5% native PAGE showing act Cl 7s ho/o-ACP dimer (top 
band) being converted to a monomeric species over 120 min. 
(b) ESMS of pure act Cl 7s ho/o-ACP dimer showing the envelope of 
charged species. (c) ESMS of pure act Cl 7s ho/o-ACP monomer 
showing the envelope of charged species. 
of this vector (pRJCOO6) into 8. coel’ico/or CH999 [28] (a 
strain lacking the ract cluster entirely) protein production 
was induced by supplementation with thiostrepton to 
5 lg/ml. As expected, large amounts of the target protein 
were produced (> 30 mg/l). Rapid cell lysis and purification 
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Purified proteins used in this study on 15% SDS PAGE. Lanes: M, 
marker (from top) 66 kDa, 45 kDa, 36 kDa, 29 kDa, 24 kDa, 20 kDa, 
14.2 kDa; A, KSICLF; B, wild-type act ho/o-ACP monomer; C, His,- 
MCAT. 
using Niz+ affinity chromatography resulted in a protein 
extract containing the act KS and CLF in apparent homo- 
geneity (Figure 3). 
We had apo and ho/o forms of both wild-type and C17S act 
ACP at our disposal, as well as commercially available 
E. co/a’ ACP. Additionally, by controlling the purification 
procedures the holo-ACPs were available as monomers or 
intramolecular disulphides or dimeric intermolecular disul- 
phides. Purified ACPs were added at known concen- 
trations to purified KS and CLF, with or without malonyl 
CoA as described below. Assays were incubated for the 
indicated times at 30°C and worked up by quenching 
with potassium phosphate and then extraction into ethyl 
acetate. The solvent was then removed and the residue 
examined using reverse-phase high-performance liquid 
chromatography (RP-HPLC) (Figure 4). In order to cal- 
ibrate the HPLC integrals SEK4 and SEK4b were puri- 
lied from S. coelicoioor CH999pSEK4 and obtained as 
homogenous solids before injection of known masses onto 
the HPLC column. 
The KSICLF protein preparation does not contain 
S. coelicolor MCAT or other transacylase activity 
We have previously shown that E. coli FAS ACP is a good 
substrate for S. coelicol’or MCAT and can be used as a 
potential assay for detecting MCAT activity in protein frac- 
tions (T.S Hitchman, R.J.C., J.C and T.J.S, unpublished 
observations). Commercially available E. coli ACP (>60% 
purity) appears to contain substantial MCAT activity, as 
incubation with t4C-labelled malonyl CoA alone resulted 
in formation of labelled protein. This activity was removed 
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A typical HPLC trace showing compounds detected at 280 nm after 
incubation of act ho/o-ACP monomer with malonyl CoA and KSlCLF 
under the conditions described in the Materials and methods section. 
by purifying the ACP by our usual procedures. Ion- 
exchange chromatography, followed by desalting yielded 
protein with substantially lower acyltransferase activity 
(Figure 5). Incubation of this purified ACP with 
14C-malonyl CoA and the KS/CLF fraction resulted in for- 
mation of labelled protein at a very low rate. Incubation of 
KS/CLF alone with 14C-malonyl CoA resulted in formation 
of labelled protein at an even lower rate. 
Holo ACP monomer is required for polyketide biosynthesis 
All current evidence points to the 4’-phosphopantetheine 
thiol of ho/o-ACP as the point of attachment for both the 
malonyl group and the growing polyketide chain. Holo- 
ACP disulphide dimer should not, therefore, be able to 
participate in polyketide biosynthesis. Polyketides were 
produced when Role-ACP monomer was added in the 
presence of malonyl CoA (Figure 4). The dimer was 
formed by resuspending ho/o-ACP in buffer not containing 
DTT. When added to the KS/CLF in the presence of 
1mM malonyl CoA and 1mM DTT polyketides were 
formed, but at a rate significantly below that observed for 
the /lolo-ACP monomer (Figure 6). Presumably monomer, 
liberated from the dimer by slow reaction with DTT, was 
able to participate in the reaction. No polyketides (SEK4 
and SEK4b) were produced when apo-ACP or E. coli FAS 
Aolo-ACP was used in the same assay. 
Time course of polyketide production 
In order to determine the best time frame for studying 
polyketide production, we examined the variation of 
Figure 5 
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Rate of formation of i4C-labelled protein in the presence of 
14C-malonyl CoA (22 PM, 1.7 GBq mmol-l). Experiments were carried 
out in the presence of 50 pM E. co/i ACP and 2.5 pM act KSICLF. 
polyketide production with time. Parallel 100 ~1 reactions 
were set up that contained KS/CLF (1.5 PM), wild-type 
act dolo-ACP monomer (50 PM), MCAT (1 PM) and 
malonyl CoA (1 mM). Reactions were initiated by the 
addition of malonyl CoA and stopped at time points over 
120 min. SEK4 and SEK4b production was assayed using 
calibrated HPLC and plotted versus time (Figure 7). After 
120 min, a total of 4.0 nmol (40 PM in 100 pl reaction) of 
polyketide had been produced. Because SEK4 and SEK4b 
are octaketides we expected 12.5 nmol of polyketide prod- 
ucts (based on one eighth of the 100 nmol malonyl CoA 
available). Although only 4.0 nmol was produced, the 
figure shows that polyketide production was still continu- 
ing at a significant rate at 120 min. The production curve 
remains essentially linear up to around 20 min and subse- 
quent assays containing up to 50 PM ACP were performed 
on this time scale, with faster assays containing >50 FM 
ACP being performed for shorter times. 
Requirement for MCAT during polyketide biosynthesis 
As expected, incubation of purified KS/CLF (1.5 PM) 
with malonyl CoA (1 mM), with or without the addition 
of MCAT (1 PM), did not result in detectable polyketide 
(SEK4 or SEK4b) production. We estimate the limits of 
our assay to be < 5 pmol of SEK4 or SEK4b, indicating 
any production of these compounds to be occurring at 
less than 0.25 pmol min-1 in standard 20 min assays. 
Addition of purified wild-type act /zolo-ACP monomer 
(2.5 ~.LM) in the presence of MCAT (1 PM) restored 
polyketide production. When the experiment was repeated 
in the absence of MCAT very low, but detectable, poly- 
ketide production was observed. Addition of further 
wild-type act tiolo-ACP monomer led to increased levels 
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Rate of polyketide (SEK4 + SEK4b) production with varying protein 
concentrations (first figure in ratio refers to KS/CLF concentration, PM; 
the second figure to ACP concentration, uM). Blue bars, rate of 
polyketide production with increasing wild-type ho/o-act ACP 
monomer concentration at 1.5 pM KSICLF. Green bar, enhancement 
in rate with general protein concentration increase. Red bars, effect of 
increasing KS/CLF concentrations. Magenta bars, use of other ACP 
species as indicated (at 50 PM). 
of SEK4 and SEK4b, however. At low ACP concentra- 
tion, that is, in the same region as the KS/CLF (<lo PM), 
the rate of polyketide production appeared to be signifi- 
cantly less than that observed in the presence of MCAT. 
Above a /lolo-ACP monomer concentration of 20 p.M no 
difference in the rate of polyketide production was 
observed (Figure 8a), however. 
Effects of varying protein concentration on polyketide 
production 
Examination of the effect of varying wild-type act Ro/o- 
ACP monomer concentration was performed by addition 
of ho/o-ACP up to 200 FM in the absence of MCAT 
(Figure 8b). The rate of polyketide production increased 
with increasing Rolo-ACP monomer concentration. There 
appeared to be no indication of saturation even at the 
highest total dolo-ACP concentration used (ZOO PM). 
In order to examine this effect more fully we incubated 
equimolar amounts of act Aol’o-ACP and KS/CLF at higher 
concentrations (Figure 6). Reactions containing 10 pM of 
Time (min) Chemistry & Biolog) 
Time course of a reaction containing 1 mM malonyl CoA, 50 uM wild- 
type act ho/o-ACP monomer, 1 uM Hiss-MCAT and 1.5 pM KWCLF. 
The maximum expected yield of octaketides is 12.5 nmol; 4.0 nmol was 
produced after 2 h. 
each of ACP/KS/CLF produced polyketides at a signifi- 
cantly lower rate than reactions containing 1.5 PM of 
KS/CLF and 10 PM ACP. Similarly reactions containing 
20 pM concentrations of all protein components produced 
polyketides at a similarly reduced rate. The effect of total 
protein concentration was also examined. Addition of 
bovine serum albumin (BSA) to 80 /.tM to a standard reac- 
tion containing 1.5 PM KS/CLF and 2.5 PM act Aolo-ACP 
led to a slightly increased rate of polyketide production of 
compared with reactions lacking BSA. 
MCAT does not operate as a thiolesterase 
A further difference between the type II PKSs and the 
modular PKSs is the apparent lack of a thiolesterase 
homologue in the gene clusters. One potential role for 
MCAT could be to act as a thiolesterase, removing the 
fully formed polyketide from the ACP. We tested this 
possibility using preformed malonyl ACP. This was 
achieved using our previously reported method of simply 
incubating the C17S act /lolo-ACP monomer with malonyl 
CoA. Malonyl-ACP was repurified and the acylated 
protein incubated with KS/CLF for 2 h at 30°C. Both SEK4 
and SEK4b were formed. In a 100 1.11 assay containing 
malonyl C17S act ACP (14.6 pM) a total of 191 pmol of 
SEK4 and SEK4b were produced (average of two runs). 
This corresponds to a quantitative yield of octaketides as 
the assay contained 1.46 nmol (that is 8 x 182 pmol) of 
available malonyl groups. 
Discussion 
We set out to study the activity of the act minimal PKS in 
vitro using rigorously purified proteins. The protein expres- 
sion strategy described previously [5,6] for production of 
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Variation in the rate of polyketide production (SEK4 and SEK4b) with 
ACP concentration. (a) Variation in the rate in the presence or 
absence of Hiss-MCAT (1 PM) at lower ACP concentrations. (b) Effect 
of increasing ACP concentration in the absence of His,-MCAT. 
act KS/CLF involved the cloning of type II PKS genes 
using the act11 ORF4 promotor system in low copy number 
vectors such as pSEK38. Hutchinson and coworkers [Zl] 
have used the emEp* promoter in a similar way for express- 
ing the tcm genes. We decided to utilise the thiostrepton 
induction system devised for Streptomyces by Bibb and 
coworkers [29]. This system provides a convenient method 
of induction by the tipA promoter and provides large 
amounts of soluble protein. Additionally, the fusing of a 
His, tag at the amino terminus sequence allowed rapid 
initial purification using Ni2+ affinity chromatography. 
We realised that potential problems could be experienced 
in purifying expressed KS/CLF/ACP complexes. Because 
there is no published data on the dissociation constants for 
components of these complexes, we decided to express the 
KS and CLF components in the absence of ACP, and then 
add our previously purified ACPs. This strategy differs 
from that used by Carreras and Khosla [23], who described 
the removal of ACP from expressed KS/CLF/ACP com- 
plexes by repeated chromatography. Our attempts to repeat 
this work using KS/CLF/ACP as expressed from pSEK4 
in S. coelicolor CH999 showed that ACP could not be 
removed completely under standard chromatographic con- 
ditions (data not shown) and that even extensively purified 
extracts displayed PKS activity without the requirement 
for additional ACP (data not shown). Our strategy allows us 
to rigorously rule out the possibility of bound act ACP, 
enabling us to titrate the amount of added ACP. Further- 
more, it allows us to probe the role of ACP by supplement- 
ing the in vitro minimal PKSs with a variety of heterologous 
and mutant ACPs. 
Our previous work with wild-type act ACP showed that 
expression from E. coli leads to production of predomi- 
nantly (> 90%) inactive ape-protein lacking the 4’-phos- 
phopantetheine prosthetic group [&I. We have been able 
to produce high levels of type II PKS Aolo-ACPs by 
coexpressing the ACP with the E. COLT ACPS such that 
act ACP is present in predominantly (> 95%) holo form 
[26]. Additionally we have shown that for wild-type act 
ACP, formation of an internal disulphide between the 
4’-phosphopantetheine terminal thiol and Cysl7 is facile 
and rapid [27]. Even in C17S mutants act halo-ACP 
rapidly dimerises through disulphide formation between 
the phosphopantetheine thiols at low DTT concentra- 
tions (1.0 mM or less) and that monomerisation by DTT 
is relatively slow (Figure Za). Because act holo-ACP 
monomer is the only active species of ACP for polyketide 
production it is important to assess the levels of Aolo-ACP 
monomer added to PKS assays using ESMS or native 
PAGE, for example (Figure 2). It is also important to 
estimate the likely concentrations of ho/o-ACP monomer 
used in published studies for comparison with the work 
reported here (see below). Act /zolo-ACP itself was 
expressed in E. coli and purified to homogeneity. Care 
was taken at all times to monitor the ratio of active act 
Aolo-ACP monomer versus inactive disulphide dimer using 
ESMS and native PAGE (Figure 2). Addition of at least 
2 mM DTT was required at all times during purification 
and Role-ACP was pre-incubated with DTT at 2 mM 
before polyketide production assays if necessary. In this 
way we could be confident that the ACP component of 
the assay was fully active. 
Initial experiments were consistent with the observations 
of Hutchinson and coworkers [24]. Reconstitution of act 
KS/CLF at 1.5 yM in the presence of 2.5 pM act Aolo-ACP 
monomer produced a mixture of the expected SEK4 and 
SEK4b metabolites at a rate of around 1 pmol mini 
(Figure 8a) in the presence of 1 mM malonyl CoA. This 
rate was substantially increased to around 8 pmol mini 
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when 1 l.tM MCAT was added. An increase in act Aolo- 
ACP monomer concentration to 10 PM similarly increased 
the rate of polyketide production in the absence of 
MCAT, however. Indeed, increasing the concentration of 
act /JO/O-ACP monomer increased the rate of polyketide 
production in a near linear fashion at concentrations above 
10 pM. No significant curvature in the plot of polyketide 
production rate versus act /JO/O-ACP concentration was 
observed at ACP concentrations up to 200 PM (Figure Sb). 
At the highest concentrations of ACP tested in these exper- 
iments polyketides were produced at a rate of approx- 
imately 650 pmol min-‘. Calculation of the rate of /rolo- 
ACP self-malonylation under these conditions (using the 
k,,, value of 0.34 min-r determined previously) [ZZ] indi- 
cates a total malonyl ACP generation rate of 6800 pmol 
min-l (or, divided by eight, 850 pmol min-’ of octake- 
tides). This shows that the rate of octaketide production is 
limited by the rate of malonyl ACP production. The effect 
of additional MCAT was marginal at ACP concentrations 
between 10 and 20 PM, and was undetectable at concen- 
trations above 20 PM ACP. 
At low ACP concentrations the rate of polyketide produc- 
tion appeared to be depressed below the value expected 
from a linear relationship between the /zolo-ACP monomer 
concentration and the rate of polyketide production. In 
order to test whether this was due to the absolute concen- 
tration of /lo/o-ACP monomer or whether it was due to the 
ratio of ACP:KS/CLF we conducted assays containing 
equimolar amounts of ACP:KS/CLF at 10 pM and 20 pM. 
The polyketide production rate was significantly dimin- 
ished as compared with the same ACP concentrations with 
1.5 pM KS/CLF. The effect of total protein concentration 
was determined by the addition of BSA (80 pM) to a stan- 
dard assay. In this case a stimulation of the rate of polyke- 
tide production was observed. Clearly the ratio of /rofo- 
ACP monomer: KWCLF is crucial in determining the rate 
of polyketide production - /lo/o-ACP must be present in 
excess over KS/CLF. 
The observed depression of polyketide synthesis at low 
/to/o-ACP monomer concentrations could be the result of a 
number of factors. One possibility is that the assays are 
conducted at a concentration where there is insufficient 
association between KS, CLF and ACP to form a produc- 
tive complex. Addition of ACP might shift this equilibrium 
(Figure 9) allowing more productive complex to be formed, 
and thus increasing the rate of polyketide production, as 
we observed. If this were the case then an increase in 
KS/CLF concentration should also increase polyketide 
production. Increasing the KS/CLF concentration, however, 
dramatically attenuates polyketide production. There 
might be a small general stimulation of polyketide produc- 
tion due to overall protein concentration, but this is clearly 
insufficient to explain the observed nonlinear rate depen- 
dence on ACP at lower concentrations. 
Figure 9 
nACP + (KS-CLF), _ nACP + mKS + mCLF 
11 
ACP(,-XJ*(KS*CLF) ,,, 
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Octaketides Chemistry & Biology 
Scheme indicating possible sequestration of ACP by the KSlCLF 
complex. The ratio (n-x)/m is unknown. Please see text for more details. 
It does not seem unreasonable to speculate that KS/CLF 
will bind Lo/o-ACP, thus reducing its free concentration in 
solution. This could thereby reduce the rate of holo-ACP 
self-malonylation at ACP concentrations below the stoi- 
chiometric amount of ACP (whether this be l:l, 21 or 
another ratio). Our results are consistent with the seques- 
tering of /lolo-ACP from solution. At concentrations above 
the stoichiometric amount of ACP, the excess free ACP is 
able to undergo self-malonylation and there is a conse- 
quent increase in the rate of polyketide production as 
malonyl ACP becomes available for the synthase complex. 
A major difficulty in interpreting the data presented here 
is caused by the methods used for quantifying the 
individual proteins. Ho/o-ACP was quantified by weighing 
freeze-dried desalted samples. Although, to the best of our 
knowledge, there is minimal remaining salt, it is difficult 
to be precise and ACP concentrations are likely to be an 
overestimate. KS/CLF concentrations were determined 
by the method of Bradford, using BSA as a standard. 
There are many reports of proteins behaving anomalously 
in Bradford assays and the actual concentrations used here 
could be different [30]. For this reason it is not possible to 
use the data presented here to determine an exact stoi- 
chiometry of KS/CLF/ACP, but it is clear from our results 
that the KS/CLF must bind at least one equivalent of 
ACP before synthesis begins efficiently. 
Our results indicate a requirement for MCAT only at Ao/o- 
ACP concentrations that are in the region of the KS/CLF 
concentration. This could be the result of a number of 
factors. One possibility is that MCAT transfers malonyl 
groups from malonyl CoA to bound ACP more effectively. 
Alternatively, MCAT might simply increase the rate of 
malonyl transfer to free /loLo-ACP. At substoichiometric 
concentrations of ACP, where most of the ACP will be 
bound, the free /lo/o-ACP concentration will be very low 
and the self-malonylation rate depressed. An alternative 
possibility is that the MCAT aids turnover by unblocking 
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stalled complexes in which the ACP thiol is blocked by an 
acetyl group. Decarboxylation of malonyl ACP has been 
invoked as a possible source of the acetyl starter unit [24]. 
The resulting acetyl group is then transferred to the free 
thiol of the KS. If the decarboxylation took place with sig- 
nificant frequency (perhaps as a side reaction) when the 
KS active site was already loaded with a partially formed 
chain, the set of proteins would be at a dead end with no 
turnover possible until one of the thiols was free. We have 
shown, however, that MCAT has no measurable acetyl- 
transferase activity (T.S Hitchman, R.J.C., J.C and T.J.S, 
unpublished observations) and so it might not be very 
effective in removing the acetyl group from ACP. 
Comparison of these results with precedents in the 
literature 
In contrast to previous reports, we have demonstrated that 
MCAT is not essential for polyketide biosynthesis in 
in vitro reconstituted minimal PKS reactions. Our results 
show that the reaction proceeds at a rate governed by the 
rate of ACP self-malonylation. At low ACP concentrations 
MCAT does, however, stimulate an increase in the rate of 
polyketide production. In contrast, Carreras and Khosla 
[23] have reported that self-malonylation of ACP is not 
observed in their system and that MCAT is an absolute 
requirement for polyketide production. They do report 
observation of some apparent autocatalytic malonylation of 
Role-ACP but have ascribed this to the use of an impure 
protein preparation, as the effect was not found on further 
purification of the ACP. Hutchinson and coworkers [24] 
report a low level of self-malonylation that would appar- 
ently account for a maximum of 10% of polyketide produc- 
tion in the tcm in vitro minimal system. These observations 
appear to reinforce the earlier reports of Revill and 
Hutchinson and coworkers [19,20] in which they did not 
observe ACP self-malonylation in MCAT assays. 
In order to explain these differences it is important to 
examine the reactivity of type II PKS ACPs used in each 
study. We have shown that Aolo-ACPs bind acyl groups 
(and presumably growing polyketide chains) as thiol esters 
to the terminal thiol of the phosphopantetheine prosthetic 
group [Z?]. The first prerequisite for ACP activity is that it 
be present in the ho/o form. E. co& expression of type II 
PKS ACPs leads to production of predominantly (some- 
times exclusively) apo-ACP as the ACPs are poor substrates 
for the endogenous E. coL ACPS. The second prerequisite 
is that the phosphopantetheine thiol is available for reac- 
tion. For wild-type act /loLo-ACP, at least, the terminal 
phosphopantetheine thiol can rapidly form an internal 
disulphide with Cysl7, or it can dimerise with another 
ACP unit. As our results show, monomerisation of the 
dimers is slow at 1 mM DTT. Dimer formation is a feature 
of all purification protocols we have examined, and it is 
particularly rapid during freeze-drying or sephadex-desalt- 
ing procedures. Addition of ACP dimers to PKS assays 
containing DTT would only slowly release free active 
ho/o-ACP monomer, resulting in slow polyketide forma- 
tion (Figure 6). For this reason it is crucial to examine the 
holo-ACPs by ESMS or native PAGE before use in PKS 
assays. Furthermore the concentration of malonyl CoA 
should be considered. We have measured a K,, for self- 
malonylation of act ACP as -200 pM, and for reactions to 
proceed with an appreciable rate, the malonyl CoA con- 
centration should be in this region [Z?]. 
The MCAT experiments of Revill [19], utilising act ACP 
expressed from E. co& used total act ACP concentrations 
of -40 FM, but only l-Z% of the 40 pM was holo-ACP. 
Thus, the concentrations of Aolo-ACP in this assay would 
likely have been 0.4-0.8 pM, which would have been 
further reduced if signiticant amounts of internal disul- 
phide with Cysl7 or disulphide dimers were present (as 
there would be after the lyophilisation step of the purifica- 
tion procedure). The malonyl CoA concentration was 
23 pM. It is clear from our previous results that ACP self- 
malonylation would be very slow at these substrate con- 
centrations. Here we have also shown that MCAT activity 
is most obvious at these low &o/o-ACP monomer concentra- 
tions. Under these conditions, therefore, it would have 
been easy to overlook ACP self-malonylation. The MCA’I 
assays reported by Hutchinson and coworkers [ZO] used 
tcm ACP isolated from S. glaucescens, which was presum- 
ably present as hoLo protein. No indication of the amounts 
of internal disulphide (Cyslb of tcm ACP is equivalent to 
the Cysl7 of act ACP) or disulphide dimers was given and 
so it is possible that the concentration of active tcm holo- 
ACP monomer present in the assays was below the 25 pM 
total ACP concentration. The malonyl CoA concentration 
in these assays was 5 pM and self-acylation of tcm ACP 
would be difficult to observe under these conditions. 
The in vitro experiments described by Carreras and 
Khosla [23] using purified components to reconstruct het- 
erologous type II PKS systems used fren ACP expressed 
in E. co/z’. The purified apo-ACP was treated with purified 
E. co/i ACPS and CoA to produce holo-ACP. Although 
earlier reports claimed up to 95% /zoLo-protein, evidence 
for the ratio of active ~OL’O-ACP monomers to inactive 
dimer has not been presented. The assays reported by this 
group have used apparent ACP concentrations of 10 pM, 
although the concentration of active /zodo-ACP monomer 
could well have been lower. Again, under these conditions 
MCAT does stimulate transfer of malonyl groups from 
CoA to Lolo-ACP, whereas self-acylation is relatively slow. 
It is perhaps worthy to note that Carreras and Khosla [23] 
did not use the homologous wild-type act ACP, which we 
now know forms a stable intramolecular disulphide, in any 
of their reported experiments. 
Interestingly Khosla, Walsh and coworkers [4] have carried 
out assays where self-malonylation of ACP might have been 
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expected to provide both the starter and extender units 
required for polyketide production. In these experiments 
14C-acetyl fren ACP was produced by incubating fren apo- 
ACP with 14C-acetyl CoA and purified E. cob ACPS in a 
reaction similar to that previously described by us [26]. This 
provided 14C-acetyl fren ACP in a form that could not 
include any inactive dimeric protein. PKS assays were then 
conducted that contained 125 PM 14C-acetyl fren ACP, 
1 mM malonyl CoA and -1 PM act KS/CLF. Although no 
MCAT was added it might have been assumed to be a com- 
ponent of the semi-pure KS/CLF preparation. The labelled 
acetyl groups initiated polyketide synthesis, and the fren 
60/o-ACP would have been released at the end of each 
round of octaketide production. 14C-Labelled product was 
quantified and shown to correspond to a quantitative yield 
of polyketides. Any unlabelled polyketides arising from 
reactions of the free fren /rolo-ACP monomer, such as we 
have described, would not have been observed by this 
method as the malonyl extender units were unlabelled. 
The experiments reported recently by Hutchinson and 
coworkers [24] have used tcm ACP obtained from 
S. glawescens as ho/o-protein. They observed slow self-acy- 
lation of ACP. The conditions reported for this reaction, 
however, utilised a very low concentration of malonyl CoA 
(2 PM) compared with the 150 PM malonyl CoA typically 
used in their polyketide production assays. Because the 
K, for malonyl CoA for act ACP self-malonylation is 
around 200 yM, self acylation would certainly be expected 
to be slow under these conditions. Our PKS assays, in 
common with those of Carreras and Khosla [23], use a 
malonyl CoA concentration of 1 mM. 
We have previously shown that our holo-ACP monomer 
preparations are free from E. coli MCAT [ZZ]. We believed 
it was necessary to rigorously exclude the possibility of 
contaminating S. coelicolor MCAT in the KS/CLF prepara- 
tion. The presence of MCAT seems unlikely as addition 
of the S. coelicolor His,-MCAT to 1 pM (i.e. approximately 
equimolar with KS/CLF) is required for the observed 
stimulation of polyketide production. Presence of MCAT 
at this level would be clearly visible in the SDS PAGE 
examination of the KS/CLF preparation. Furthermore, 
KS/CLF preparations were inactive in assays to measure 
the transfer of malonyl groups from 14C-malonyl CoA to 
E. coli FAS ACP, which we have shown previously is a 
good substrate for S. coelicolor MCAT (T.S. Hitchman, 
R.J.C., J.C. and T.J.S, unpublished observations). At best 
the KS/CLF preparation used here could generate malonyl 
ACP at around 15 nM min-l, a rate insufficient for the 
observed rapid production of polyketides (-8000 nM min-1 
is required under similar conditions). 
Requirement for MCAT 
MCAT is clearly not required for polyketide biosynthesis 
in vitro when the concentration of act /~o~o-ACP monomer 
is appreciably larger than the KS/CLF concentration. At 
lower ACP concentrations the effect of additional MCAT 
is an increase of the rate of polyketide production. Under 
these conditions the free holo-ACP monomer concentra- 
tion is likely to be low because of sequestration by 
KS/CLF and self-acylation is depressed. It might be that 
MCAT is efficient at stimulating malonyl transfer to very 
low concentrations of act dolo-ACP monomer, or that it can 
efficiently transfer malonyl groups to bound Role-ACP. 
The in viva concentrations of MCAT, KS/CLF, ACP and 
malonyl CoA are unknown and it is not possible to deter- 
mine the requirement for MCAT in vivo. 
Starter unit 
Our assays contained no exogenous acetyl CoA, although 
commercial sources of malonyl CoA are known to contain 
acetyl CoA at low levels. Our previous results have shown 
that neither MCAT nor act holo-ACP can catalyse the trans- 
fer of acetyl groups from CoA onto holo-ACP. Because the 
acetyl group is required by the synthase as a ‘starter unit’ it 
must be derived using one or other of two mechanisms. 
The act KS/CLF might contain an acetyl-transferase activ- 
ity that could utilise acetyl CoA impurities in the malonyl 
CoA. This would seem unlikely given the results of 
Sherman and coworkers [14] which show that the putative 
AT domain of KS is unnecessary for act biosynthesis in vivo. 
Alternatively, we have shown here that KS/CLF in the 
presence of purified malonyl ACP produces exactly the 
expected amount of octaketides. Secondly, decarboxylation 
of malonyl ACP could be catalysed by KS/CLF. We have 
shown previously that act malonyl ACP can catalyse decar- 
boxylation of the malonyl group, but only under conditions 
of partial defiaturation [ZZ]. Thus efficient production of 
acetyl ACP would need to be catalysed by a separate entity. 
The point at which this decarboxylation could take place is 
uncertain, as there is no mechanistic requirement for the 
terminal carboxyl group to be lost before subsequent elon- 
gation events. Analogy with FAS would suggest production 
of acetyl ACP as a starter unit. Acetyl ACP, derived by 
treatment of apo-ACP with acetyl CoA and ACPS, has been 
shown to be capable of initiating polyketide biosynthesis in 
vitro by Carreras et al. [S]. It is also conceivable that decar- 
boxylation could also be a later-stage event. This could be a 
clue to understanding the biosynthesis of oxytetracycline 
where malonyl or malonoamyl groups appear to be the 
starter unit in polyketide biosynthesis. 
Rate of polyketide production 
Our results show that for the reconstituted homologous act 
type II PKS, which consists of KS, CLF and ACP, the rate 
of polyketide production depends upon the concentration 
of the act hoJo-ACP monomer. Act hoJo-ACP disulphide 
dimer only releases active ACP monomer slowly on reac- 
tion with 1 mM DTT, and polyketide production by the 
KS/CLF/ACP complex was depressed well below the level 
observed for active AoJo-ACP monomer. Neither E. cob FAS 
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/&Jo-ACP nor act upo-ACP is active in the reaction. The lim- 
iting step in polyketide synthesis for the act KS/CLF/ACP 
complex seems to be the transfer of malonate from CoA to 
ACP. This is clearly not possible for assays utilising either 
apo-ACP or FAS ACP. The overall reaction is not depen- 
dent on S. coelicolor MCAT in vitro. 
Significance 
Studies on the mechanism of polyketide chain assembly 
catalysed by type II polyketide synthases (PKSs) require 
development of in titro systems comprising the minimal 
components of the PKS complex necessary for de nova 
polyketide synthesis. In viva studies indicated that the 
minimal system comprised the ketosynthase (KS) and 
‘chain length factor’ (CLF) along with the acyl carrier 
protein (ACP), whereas recent in vitro studies suggested 
an additional requirement for malonyl CoA: ACP 
transacylase (MCAT) to catalyse transfer of malonate 
from malonyl CoA to the ACP. This latter result con- 
trasted with studies which had demonstrated that type II 
PKS hof+ACPs were capable of self-malonylation. This 
apparent contradiction has been resolved and exact con- 
ditions for in vitro polyketide synthesis have been defined. 
The concentration of holo ACP monomer appears to be 
rate-limiting for the production of polyketides by the 
minimal act PKS. The overall rate of polyketide produc- 
tion is of the order of magnitude expected if self-acylation 
of the ACP is the slowest step during polyketide biosyn- 
thesis. These observations are clearly supported by the 
in vivo experiments of Decker et al. [31] who showed that 
the level of tetracenomycin (tcm) production is enhanced 
when the tcm ACP is overexpressed in S. glaucescens. 
The accurate measurement of kinetic constants for 
MCAT activity and ACP self-acylation leads us no 
closer to an understanding of the in viva conditions 
leading to actinorhodin synthesis in S. coelicolor. The sig- 
nificance of these in vitro measurements to the in vivo sit- 
uation await the determination of in vivo protein and 
substrate concentrations. We have determined, however, 
that the rate of polyketide production depends on the 
ratio of KS/CLF to ACP. MCAT might be required for 
efficient polyketide production in vivo if the free holo- 
ACP concentration is low, but the synthase can operate 
without the aid of MCAT. 
The self-acylation mechanism could represent a fossil 
activity of the act PKS. The clustering of the genes for 
act biosynthesis (and very many other polyketide sec- 
ondary metabolites), together with appropriate resis- 
tance genes, could be a relic of gene dispersion events in 
the past. For a set of genes to be preserved by an organ- 
ism they should confer a selective advantage (e.g. pro- 
duction of, and self-resistance to, a useful antibiotic). A 
gene cluster transferred from one heterologous organ- 
ism to another that was unable to initiate its synthesis 
because of incompatibility with the host’s MCAT 
would not, presumably, confer any evolutionary advan- 
tage on the organism. A protein that was able to obtain 
a malonyl group from its host, either through self-acyla- 
tion or through adventitious interaction with MCAT, 
would be able to produce polyketides and become useful 
to the organism. A self-acylation mechanism would be a 
clear initial advantage. Later evolution could lead to 
enhanced polyketide production if the ACP were able to 
better interact with the host’s fatty acid synthase 
(FAN MCAT. The use of a separate MCAT by FAS 
systems might be a reflection of the additional control 
processes required for the crucial primary metabolism 
of fatty acids. 
The demonstration of the true minimal requirements for 
polyketide synthesis in vitro should facilitate further in 
vitro studies to clarify the exact role of each PKS com- 
ponent and the exact mechanisms of polyketide chain 
assembly, cyclisation and reductive modifications. This, 
in turn, should allow a more complete assessment to be 
made of the real potential for genetic manipulations of 
type II PKSs to provide novel compounds by rational 
design. 
Materials and methods 
Cloning, expression and purification of act/ ORFs 1 and 2 
(KS and CLF) 
Standard procedures were adopted unless otherwise indicated [32,33]. 
A pBluescript vector containing an 8.8 kb fragment of the act cluster 
between Pstl-12 and WI-20 [34] was digested with Sad. The vector 
and a 2.82 kb Sad fragment were gel purified [35]. The vector, now 
containing a 1.89 kb genomic fragment including the first 205 base 
pairs of act1 ORF 1 was recloned with T4 DNA ligase and cloned into 
E. co/i DH5a. The cloned vector was used as a PCR template using the 
pBluescript reverse primer and a synthetic oligonucleotide 5’-CATAT- 
GAAGCGCAGAGTCGTCATCAC-3’ containing the sequence for Ndel 
(5’~CATATG-3’) overlapping the first codon. The primers were phospho- 
rylated before use. The PCR conditions were: 96’C for 1 min, then 
64°C for 45 s, then 72’C for 2 min, repeated 25 times. Vent DNA poly- 
merase (NEB) was used, together with a Mg*+ concentration of 4 mM 
and other conditions as specified by the suppliers. A blunt-ended 
product of the expected 220 base pairs was gel purified and ligated into 
the dephosphorylated Smal site of pBluescript. After transformation into 
f. co/i DH5a the sequence was checked by manual sequencing 
(Promega). One positive clone that contained no unwanted mutations 
was then linearised with Sac1 and the 2.82 kilobase Sad fragment con- 
taining the rest of acd ORFl, and complete ORFs 2 and 3 was ligated 
into this. After transformation into f. co/i DH5a the direction of cloning 
was checked by restriction analysis. One positive clone was designated 
as pRJCllO4F and was used for further manipulations. 
For construction of an expression clone containing only KS and CLF, 
pRJCllO4F was digested with Ndel and Ncol. The resulting 2.5 kilo- 
base fragment was ligated between the Ndel and Ncol sites of 
pLitmus28 (NEB) and re-excised as a Ndel-EcoRI fragment. This was 
then ligated between the Ndel and EcoRl sites of plJ4122 followed by 
transformation into S. lividam. Positive clones were selected by PCR 
analysis of inserts directly from lysed protoplasts. One positive clone, 
designated pRJCOO6, was transformed into S. coelicolor CH999. 
Spores of S. coelicolor CH999 pRJCO06 were grown in 5 ml of Super 
YEME containing kanamycin 50 pg/ml for 3 days at 30°C shaking at 
250 rpm. The mycelia were then transferred to 50ml of Super YEME 
containing kanamycin at 50 pg/ml and grown as before for a further 
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48 h. Induction was performed by addition of thiostrepton to 5 Fglml 
and growth was continued as before for another 24 h. Cells were har- 
vested by centrifugation and resuspended in 40 ml of 0.15 M KH,PO, 
pH 7.5 containing 10% glycerol and frozen. A ceil-free protein extract 
was prepared according to the method of Carreras et a/. [6] and then 
the buffer exchanged by sepharose chromatography to 0.1 M KH,PO,, 
0.5 M NaCI, 10% glycerol, pH7.5. The entire extract was loaded onto a 
nickel affinity column (Novagen, 0.5 ml). The column was eluted with 
0.1 M KH,PO,, 0.5M NaCI, 10% glycerol buffer containing increasing 
amounts of imidazole: 0.0 mM, 2 ml; 1 .O mM, 1.5 ml; 2.5 mM, 1.5 ml; 
5 mM, 1.5 ml; 10 mM, 1 ml; 20 mM, 1 ml; 50 mM, 1 ml; 500 mM, 1 ml. 
Fractions containing 50 mM and 500 mM imidazole contained the 
required protein (SDS PAGE), but the 500 mM cut was of significantly 
higher purity. The 500 mM fraction was desalted into 0.1 M KH,PO,, 
2 mM DTT, 2 mM EDTA, 10% glycerol at pH 7.3 to a total volume of 
2.2 ml. Bradford protein assay indicated protein was present at 
0.69 mg/ml. This protein fraction was used for all further assays. 
Expression, purification and acylation of act I ORF3 (ACP) 
Expression and purification of ho/o-ACPs was as described previously 
[25,26]. Disulphide dimers were prepared by resuspension of freeze- 
dried purified ho/o-ACPs in 100 mM phosphate buffer pH 7.5 contain- 
ing no DTT, or by desalting using a sepharose column and buffers not 
containing DTf. Purified ACP dimer was analysed by native PAGE and 
ESMS. Malonylation of ACP was achieved by incubation of ho/o-ACP 
monomer (43 FM) with malonyl CoA (1.2 mM) for 30 min in phosphate 
buffer pH 7.3 containing 2.0 mM Dll at 30°C. Malonyl ACP was puri- 
fied by desalting against phosphate buffer pH 7.3 without Dll using 
sepharose chromatography. ACP was quantified by weighing desalted 
freeze-dried purified protein. 
Expression and purification of fabD (MCA T) 
Hiss-MCAT was expressed and purified from E. co/i as described previ- 
ously (TS Hitchman, R.J.C., J.C. and T.J.S, unpublished observations). 
Determination of MCA T activity of purified KS/CLF fraction 
.E. co/i FAS ACP (Sigma) was puriiied according to our previously 
reported methods 1251. Reactions contained 14C-malonyl CoA (1.7 GBq 
mmol-l, 22 FM) and as appropriate ACP (50pM) and/or KS/CLF 
(2.5 PM) made up to a total volume of 10 pl with 50 mM phosphate 
buffer, pH 6.5 containing 2 mM Dll. Assays were conducted for 30 min 
at 30°C then were quenched by addition of BSA (30 pl, 100 mg/ml) and 
TCA (30 ~1, 50%). Protein was precipitated at O’C for 10 min, then pel- 
leted (13000 rpm, 10 min). The supernatant was discarded and the 
pellet washed with 10% ice cold TCA. The pellet was resuspended in 
2 N NaOH (50 pl) and 2 N Tris (50 ~1) and the solution counted. Reac- 
tions and controls were performed in triplicate. 
Polyketide synthase assay and HPLC analysis 
SEK4 and SEK4b were purified from a culture of S. coelicolor CH999 
pSEK4 (gift of Chaitan Khosla) grown on solid R5 media [34] for 7 days 
at 30°C. 60 Plates were diced and extracted with a solution of ethyl 
acetate and methanol (4:1, 3 x 1 I). The organic extracts were dried 
(MgSO,), evaporated to dryness and the brown residue mixed with 
ethyl acetate (200 ml). The resulting suspension was filtered and the fil- 
trate evaporated in vacua. The solid residue was dissolved in the 
minimum amount of methanol at room temperature. The solution was 
cooled to -2O’C overnight and the precipitate of crude SEK4b 
(200 mg) collected by filtration as a pale cream powder. The super- 
natant was evaporated to dryness and dissolved in the minimum amount 
of ethyl acetate and then purified by flash chromatography according to 
the method of Still et a/. [36]. Crude SEK4 was eluted with acetonitrile 
and obtained as a brown powder (60 mg). SEK4 and SEK4b were puri- 
fied by RP HPLC using the following method. Solvent A 0.05% trifluo- 
roacetic acid in water; solvent B 0.045% trifluoroacetic acid in 
acetonitrile; Column Rainin Microsorb C,, 30 x 1 cm eluted at 4 mllmin, 
observed simultaneously at 254 nm and 280 nm. Injections of approxi- 
mately 1 mg of either crude SEK4 or crude SEK4b were made and the 
column eluted for 5 min at 0% B. A gradient to 75% B was then made 
over 30 min. SEK4 was eluted at 26 min after injection, SEK4b after 
28 min. ‘H NMR analyses for each compound agreed with published 
data. Puriiied compounds were used to calibrate further HPLC analysis. 
Polyketide synthase assays were performed at 30°C for between 5 and 
20 min in 100 mM phosphate buffer, pH 7.3 containing 2 mM DTT and 
2 mM EDTA in a total final volume of 100 ~1. After incubation the 
assays were quenched by addition of 100 mg of solid NaH,PO,, then 
extracted with ethyl acetate (2 x 500 J.LI). The organic extract was evap- 
orated and the residue dissolved in methanol (130 ~1). 59 pl of the 
extract was injected onto a Luna(2) C,, RP-column 250 x 4.6 mm 
(Phenomenex). The column was eluted at 1 mllmin for 5 min at 09/oB. A 
gradient to 75%B was then made over 30 min. SEK4 was eluted at 
approx 21 min after injection, SEK4b after approx 22 min. 
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